These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38965928)

  • 21. Structure and Function of Cationic and Ionizable Lipids for Nucleic Acid Delivery.
    Sun D; Lu ZR
    Pharm Res; 2023 Jan; 40(1):27-46. PubMed ID: 36600047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Ionizable Lipid Nanoparticles for SARS-CoV-2 Omicron mRNA Delivery.
    Long J; Yu C; Zhang H; Cao Y; Sang Y; Lu H; Zhang Z; Wang X; Wang H; Song G; Yang J; Wang S
    Adv Healthc Mater; 2023 May; 12(13):e2202590. PubMed ID: 36716702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular Delivery of mRNA for Cell-Selective CRISPR/Cas9 Genome Editing using Lipid Nanoparticles.
    Ma T; Chen X; Wang M
    Chembiochem; 2023 May; 24(9):e202200801. PubMed ID: 36780174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs.
    Bogaert B; Sauvage F; Guagliardo R; Muntean C; Nguyen VP; Pottie E; Wels M; Minnaert AK; De Rycke R; Yang Q; Peer D; Sanders N; Remaut K; Paulus YM; Stove C; De Smedt SC; Raemdonck K
    J Control Release; 2022 Oct; 350():256-270. PubMed ID: 35963467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SMART-lipid nanoparticles enabled mRNA vaccine elicits cross-reactive humoral responses against the omicron sub-variants.
    Mahalingam G; Rachamalla HK; Arjunan P; Karuppusamy KV; Periyasami Y; Mohan A; Subramaniyam K; M S; Rajendran V; Moorthy M; Varghese GM; Mohankumar KM; Thangavel S; Srivastava A; Marepally S
    Mol Ther; 2024 May; 32(5):1284-1297. PubMed ID: 38414245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics.
    Mukai H; Ogawa K; Kato N; Kawakami S
    Drug Metab Pharmacokinet; 2022 Jun; 44():100450. PubMed ID: 35381574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cationic Lipid Pairs Enhance Liver-to-Lung Tropism of Lipid Nanoparticles for In Vivo mRNA Delivery.
    Zeng G; He Z; Yang H; Gao Z; Ge X; Liu L; Liu Z; Chen Y
    ACS Appl Mater Interfaces; 2024 May; 16(20):25698-25709. PubMed ID: 38717294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enabling online determination of the size-dependent RNA content of lipid nanoparticle-based RNA formulations.
    Jia X; Liu Y; Wagner AM; Chen M; Zhao Y; Smith KJ; Some D; Abend AM; Pennington J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Dec; 1186():123015. PubMed ID: 34741934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
    Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
    Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications.
    Jeong M; Lee Y; Park J; Jung H; Lee H
    Adv Drug Deliv Rev; 2023 Sep; 200():114990. PubMed ID: 37423563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The nano delivery systems and applications of mRNA.
    Li M; Li Y; Li S; Jia L; Wang H; Li M; Deng J; Zhu A; Ma L; Li W; Yu P; Zhu T
    Eur J Med Chem; 2022 Jan; 227():113910. PubMed ID: 34689071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overcoming thermostability challenges in mRNA-lipid nanoparticle systems with piperidine-based ionizable lipids.
    Hashiba K; Taguchi M; Sakamoto S; Otsu A; Maeda Y; Ebe H; Okazaki A; Harashima H; Sato Y
    Commun Biol; 2024 May; 7(1):556. PubMed ID: 38730092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles.
    Yanez Arteta M; Kjellman T; Bartesaghi S; Wallin S; Wu X; Kvist AJ; Dabkowska A; Székely N; Radulescu A; Bergenholtz J; Lindfors L
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3351-E3360. PubMed ID: 29588418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic Studies of an Automated Lipid Nanoparticle Reveal Critical Pharmaceutical Properties Associated with Enhanced mRNA Functional Delivery In Vitro and In Vivo.
    Cui L; Hunter MR; Sonzini S; Pereira S; Romanelli SM; Liu K; Li W; Liang L; Yang B; Mahmoudi N; Desai AS
    Small; 2022 Mar; 18(9):e2105832. PubMed ID: 34914866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of drug delivery technologies in the success of COVID-19 vaccines: a perspective.
    Labouta HI; Langer R; Cullis PR; Merkel OM; Prausnitz MR; Gomaa Y; Nogueira SS; Kumeria T
    Drug Deliv Transl Res; 2022 Nov; 12(11):2581-2588. PubMed ID: 35290656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mRNA delivery technologies: Toward clinical translation.
    Gómez-Aguado I; Rodríguez-Castejón J; Beraza-Millor M; Rodríguez-Gascón A; Del Pozo-Rodríguez A; Solinís MÁ
    Int Rev Cell Mol Biol; 2022; 372():207-293. PubMed ID: 36064265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells.
    Patel SK; Billingsley MM; Frazee C; Han X; Swingle KL; Qin J; Alameh MG; Wang K; Weissman D; Mitchell MJ
    J Control Release; 2022 Jul; 347():521-532. PubMed ID: 35569584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elucidation of lipid nanoparticle surface structure in mRNA vaccines.
    Wang MM; Wappelhorst CN; Jensen EL; Chi YT; Rouse JC; Zou Q
    Sci Rep; 2023 Oct; 13(1):16744. PubMed ID: 37798336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unsaturated, Trialkyl Ionizable Lipids are Versatile Lipid-Nanoparticle Components for Therapeutic and Vaccine Applications.
    Lam K; Leung A; Martin A; Wood M; Schreiner P; Palmer L; Daly O; Zhao W; McClintock K; Heyes J
    Adv Mater; 2023 Apr; 35(15):e2209624. PubMed ID: 36680477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing.
    El-Mayta R; Padilla MS; Billingsley MM; Han X; Mitchell MJ
    J Vis Exp; 2023 Jan; (191):. PubMed ID: 36744791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.